Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001390478-14-000075
Filing Date
2014-11-20
Accepted
2014-11-20 16:23:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a424b5-lp.htm 424B5 454483
2 GRAPHIC modifieddocumentgalen_image1.jpg GRAPHIC 12851
3 GRAPHIC modifieddocumentgalen_image3.jpg GRAPHIC 177196
4 GRAPHIC pipeline13nov1copy.jpg GRAPHIC 298500
  Complete submission text file 0001390478-14-000075.txt   1129401
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-188849 | Film No.: 141239299
SIC: 2834 Pharmaceutical Preparations